Vor Biopharma logo

Vor Biopharma Share Price (NASDAQ: VOR)

$1.97

-0.04

(-1.99%)

Last updated on

Check the interactive Vor Biopharma Stock chart to analyse performance

Vor Biopharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.95
    Today's High:$2.11

    Day's Volatility :7.36%

  • 52 Weeks Low:$0.13
    52 Weeks High:$3.29

    52 Weeks Volatility :96.02%

Vor Biopharma Stock Returns

PeriodVor Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
738.67%
3.6%
0.0%
6 Months
106.41%
-7.7%
0.0%
1 Year
135.81%
-12.6%
0.0%
3 Years
-62.99%
9.5%
-4.7%

Vor Biopharma Inc Key Stats

Check Vor Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.01
Open
$2.06
Today's High
$2.105
Today's Low
$1.95
Market Capitalization
$254.6M
Today's Volume
$3.6M
52 Week High
$3.29
52 Week Low
$0.1311
Revenue TTM
$0.0
EBITDA
$-332.1M
Earnings Per Share (EPS)
$-13.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-125.43%

Stock Returns calculator for Vor Biopharma Stock including INR - Dollar returns

The Vor Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vor Biopharma investment value today

Current value as on today

₹2,42,634

Returns

₹1,42,634

(+142.63%)

Returns from Vor Biopharma Stock

₹1,37,349 (+137.35%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Vor Biopharma Stock

-80.56%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Vor Biopharma Shares from India has dropped by -80.56% over the past 30 days, indicating reduced transactional activity.

-67%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Vor Biopharma Stock from India on INDmoney has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vor Biopharma Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    31.31%

  • FMR Inc

    5.07%

  • 5AM Venture Management, LLC

    5.02%

  • Vanguard Group Inc

    1.51%

  • Johnson & Johnson

    0.85%

  • Renaissance Technologies Corp

    0.55%

Analyst Recommendation on Vor Biopharma Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Vor Biopharma(by analysts ranked 0 to 5 stars)

Vor Biopharma Share Price Target

What analysts predicted

Downside of 40.36%

Target:

$1.18

Current:

$1.97

Vor Biopharma share price target is $1.18, a slight Downside of 40.36% compared to current price of $1.97 as per analysts' prediction.

Vor Biopharma Stock Insights

  • Price Movement

    In the last 3 months, VOR stock has moved up by 883.0%
  • VOR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 172.3%

Vor Biopharma Technicals Summary

Sell

Neutral

Buy

Vor Biopharma is currently in a neutral trading position according to technical analysis indicators.

Vor Biopharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Vor Biopharma Inc logo
-6.43%
106.41%
135.81%
-62.99%
-90.44%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Vor Biopharma Inc

Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. The company offers the Vor Bio platform, a technology platform for the treatment of acute myeloid leukemia (AML) and other blood cancers. It develops tremtelectogene empogeditemcel (trem-cel), a genome-edited hematopoietic stem and progenitor allogeneic donor product candidate to treat acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and other blood cancers; trem-cel in combination with Mylotarg to treat patients in VBP101, which is in phase 1 / 2; and VCAR33, a CAR-T therapy designed to target CD33, which is under preclinical studies to treat AML post-transplant. The company also develops trem-cel + VCAR33 treatment system, CD33-directed CAR-T program, which is under pre-clinical studies for the treatment of AML; VADC45 for the treatment of hematologic malignancies, conditioning, and immune reset, which is under preclinical studies; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-edited HSC therapy and a CD33-CLL1 multi-specific CAR-T therapy, which is under preclinical studies for the treatment of AML. It has a license agreement with Columbia University and the National Institutes of Health for patents; and with Editas Medicine, Inc. for ex-vivo Cas9 gene-edited HSC therapies for the treatment and/or prevention of hematological malignancies. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Vor Biopharma
Employees
154
CEO
Dr. Robert Ang M.B.A., M.D., MBBS
Industry
Services

Key Management of Vor Biopharma Inc

NameTitle
Dr. Robert Ang M.B.A., M.D., MBBS
Strategic Advisor
Mr. Sandesh Mahatme L.L.M.
Chief Business Officer & CFO
Ms. Tania Philipp
Chief People Officer
Dr. Qing Zuraw M.B.A., M.D., M.P.H.
Chief Development Officer
Mr. Dallan Murray
Chief Commercial Officer

Important FAQs about investing in VOR Stock from India :

What is Vor Biopharma share price today?

Vor Biopharma share price today is $1.97 as on at the close of the market. Vor Biopharma share today touched a day high of $2.11 and a low of $1.95.

What is the 52 week high and 52 week low for Vor Biopharma share?

Vor Biopharma share touched a 52 week high of $3.29 and a 52 week low of $0.13. Vor Biopharma stock price today i.e. is closed at $1.97, lower by 40.12% versus the 52 week high.

How to invest in Vor Biopharma Stock (VOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vor Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vor Biopharma Shares that will get you 0.7614 shares as per Vor Biopharma share price of $1.97 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Vor Biopharma Stock (VOR) from India?

Indian investors can start investing in Vor Biopharma (VOR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Vor Biopharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Vor Biopharma share’s latest price of $1.97 as on August 30, 2025 at 1:29 am IST, you will get 5.0761 shares of Vor Biopharma. Learn more about fractional shares .

What are the returns that Vor Biopharma has given to Indian investors in the last 5 years?

Vor Biopharma stock has given -90.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?